Dual Screen for Efficacy and Toxicity Identifies HDAC Inhibitor with Distinctive Activity Spectrum for BAP1-Mutant Uveal Melanoma

Overview of attention for article published in Molecular Cancer Research, February 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 36 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 1,945 followers.

Congrats Jeffim! Was an exciting project to be a part of!

Dual screen for efficacy and toxicity identifies HDAC inhibitor with distinctive activity spectrum for BAP1-mutant uveal melanoma. https://t.co/S9lZGBkj70 https://t.co/QzMtbMPEbh

RT @cwilliamszf: Dual screen for efficacy and toxicity identifies HDAC inhibitor with distinctive activity spectrum for BAP1-mutant uveal m…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.